PedAM
Pediatric Disease Annotations & Medicines
| Disease | otitis media |
| Symptom | C0029883|middle ear effusion |
| Sentences | 5 |
| PubMedID- 24628335 | Conclusions: eosinophil cationic protein (ecp) concentrations in middle ear effusion (mee) in patients with eosinophilic otitis media (eom) were significantly decreased at 3 months after the administration of omalizumab from the baseline level (p < 0.05). |
| PubMedID- 25147680 | Chronic otitis media is characterized with middle ear effusion for at least three months without clinical manifestation. |
| PubMedID- 24359096 | Intractable otitis media with eosinophil-enriched middle ear effusion was named as eosinophilic otitis media (eom) by tomioka et al. |
| PubMedID- 23393551 | Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target. |
| PubMedID- 22018357 | Background: bacteria which are metabolically active yet unable to be cultured and eradicated by antibiotic treatment are present in the middle ear effusion of children with chronic otitis media with effusion (come) and recurrent acute otitis media (raom). |
Page: 1